[{"address1": "Ole Maal\u00f8es Vej 3", "address2": "Copenhagen N", "city": "Copenhagen", "zip": "2200", "country": "Denmark", "phone": "45 70 70 29 80", "website": "https://www.iobiotech.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive mechanisms mediated by Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 2 clinical trial to treat lung, head and neck, bladder, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide designed to target T cells that recognize epitopes derived from Arginase 1 for the treatment of cancers. The company was incorporated in 2014 and is based in Copenhagen, Denmark.", "fullTimeEmployees": 74, "companyOfficers": [{"maxAge": 1, "name": "Dr. Qasim Iftikhar Ahmad M.D.", "age": 52, "title": "Chief Medical Officer", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 503280, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Inge Marie Svane M.D., Ph.D.", "title": "Founder & Clinical Advisor", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Mads Hald Andersen M.D., Ph.D.", "title": "Co-Founder & Scientific Advisor", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Anders  Ljungqvist", "title": "Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Per Thor Straten", "title": "Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Amy B. Sullivan M.B.A.", "age": 52, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 391236, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric  Faulkner M.B.A.", "title": "Chief Technical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel G. Mannix Ph.D.", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Faical  Miyara Ph.D.", "title": "Chief Business Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Marjan  Shamsaei Pharm.D.", "title": "Senior VP of Commercial Development & Portfolio Lead", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.97, "open": 0.9315, "dayLow": 0.93, "dayHigh": 0.9795, "regularMarketPreviousClose": 0.97, "regularMarketOpen": 0.9315, "regularMarketDayLow": 0.93, "regularMarketDayHigh": 0.9795, "beta": 0.419, "forwardPE": -0.74300325, "volume": 60889, "regularMarketVolume": 60889, "averageVolume": 347271, "averageVolume10days": 124700, "averageDailyVolume10Day": 124700, "bid": 0.9534, "ask": 0.955, "bidSize": 100, "askSize": 100, "marketCap": 62982140, "fiftyTwoWeekLow": 0.66, "fiftyTwoWeekHigh": 1.85, "fiftyDayAverage": 0.87288, "twoHundredDayAverage": 1.14845, "currency": "USD", "enterpriseValue": -34685924, "floatShares": 27841933, "sharesOutstanding": 65880900, "sharesShort": 200923, "sharesShortPriorMonth": 317530, "sharesShortPreviousMonthDate": 1727654400, "dateShortInterest": 1730332800, "sharesPercentSharesOut": 0.0031, "heldPercentInsiders": 0.00235, "heldPercentInstitutions": 0.76791, "shortRatio": 1.89, "shortPercentOfFloat": 0.0083, "impliedSharesOutstanding": 65880900, "bookValue": 2.021, "priceToBook": 0.47303316, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -88004000, "trailingEps": -1.29, "forwardEps": -1.17, "enterpriseToEbitda": 0.372, "52WeekChange": -0.43431956, "SandP52WeekChange": 0.19995654, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "IOBT", "underlyingSymbol": "IOBT", "shortName": "IO Biotech, Inc.", "longName": "IO Biotech, Inc.", "firstTradeDateEpochUtc": 1636119000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "ea2848e4-aa90-3bf4-82a5-9ce691c6a8c0", "messageBoardId": "finmb_1685354464", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.956, "targetHighPrice": 12.0, "targetLowPrice": 6.0, "targetMeanPrice": 9.0, "targetMedianPrice": 9.0, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 100747000, "totalCashPerShare": 1.529, "ebitda": -93157000, "totalDebt": 2150000, "quickRatio": 7.417, "currentRatio": 7.845, "debtToEquity": 2.233, "returnOnAssets": -0.50976, "returnOnEquity": -0.87657, "freeCashflow": -51137124, "operatingCashflow": -80699000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-09"}]